FI821123A0 - LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT - Google Patents

LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT

Info

Publication number
FI821123A0
FI821123A0 FI821123A FI821123A FI821123A0 FI 821123 A0 FI821123 A0 FI 821123A0 FI 821123 A FI821123 A FI 821123A FI 821123 A FI821123 A FI 821123A FI 821123 A0 FI821123 A0 FI 821123A0
Authority
FI
Finland
Prior art keywords
anvaendbara
local
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
FI821123A
Other languages
Finnish (fi)
Other versions
FI821123L (en
Inventor
Joachim Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/en
Priority claimed from CH2631/81A external-priority patent/CH647149A5/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI821123A0 publication Critical patent/FI821123A0/en
Publication of FI821123L publication Critical patent/FI821123L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI821123A 1981-04-06 1982-03-31 LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT FI821123L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (2)

Publication Number Publication Date
FI821123A0 true FI821123A0 (en) 1982-03-31
FI821123L FI821123L (en) 1982-10-07

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821123A FI821123L (en) 1981-04-06 1982-03-31 LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT

Country Status (16)

Country Link
AU (1) AU564570B2 (en)
CA (1) CA1192496A (en)
DE (1) DE3212053A1 (en)
DK (1) DK155882A (en)
ES (1) ES8308698A1 (en)
FI (1) FI821123L (en)
FR (1) FR2502951B1 (en)
GB (2) GB2098865B (en)
GR (1) GR75462B (en)
IL (1) IL65424A0 (en)
IT (1) IT8220611A0 (en)
MY (1) MY8600571A (en)
NL (1) NL8201413A (en)
NZ (1) NZ200232A (en)
PT (1) PT74703B (en)
SE (1) SE8202172L (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (en) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (en) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner HIGHLY DISPERSAL PHARMACEUTICAL MULTI-COMPONENT SYSTEMS AND METHOD FOR THEIR PRODUCTION
WO1985003878A1 (en) * 1984-03-01 1985-09-12 Sandoz Ag Pharmaceutical compositions
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (en) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk Anti-inflammatory and analgesic application agent
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (en) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate for the inhibition of acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (en) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh HIGH DISPERSES PHARMACEUTICAL COMPOSITION
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (en) * 1991-04-19 1999-12-23 Lds Technologies, Inc. CONVERTIBLE MICROEMULSION CONNECTIONS
HU223343B1 (en) * 1991-05-20 2004-06-28 Novartis Ag. Compositions comprising allylamine derivatives, and process for their preparation
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (en) * 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (en) 1992-09-25 2002-06-16 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS.
JPH08505367A (en) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション Pharmaceutical emulsion composition
WO1994019000A1 (en) * 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions containing pharmaceutical compositions
EP0789580B1 (en) 1994-11-03 2002-06-05 Novartis AG Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
DE4442999A1 (en) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmaceutical composition containing an active loratidine metabolite
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
ES2229473T3 (en) 1997-01-30 2005-04-16 Novartis Ag PHARMACEUTICAL COMPOSITIONS WITHOUT OIL CONTAINING CYCLOSPORINE A.
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (en) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
UY25225A1 (en) 1997-10-29 2000-12-29 Smithkline Beecham Plc PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (en) * 1998-06-10 1999-12-16 Labtec Gmbh New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion
PL348193A1 (en) 1998-12-11 2002-05-06 Pharmasolutions Self-emulsifying compositions for drugs poorly soluble in water
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CA2529528A1 (en) * 2003-06-20 2004-12-29 Ronald Aung-Din Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (en) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (en) * 1977-01-14 1982-09-30 Sandoz Ag Method for producing new heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
GB2098865A (en) 1982-12-01
PT74703A (en) 1982-05-01
NL8201413A (en) 1982-11-01
ES511169A0 (en) 1983-10-01
CA1192496A (en) 1985-08-27
FI821123L (en) 1982-10-07
GB8408654D0 (en) 1984-05-16
GR75462B (en) 1984-07-20
FR2502951A1 (en) 1982-10-08
IT8220611A0 (en) 1982-04-06
PT74703B (en) 1984-05-30
FR2502951B1 (en) 1985-12-06
AU564570B2 (en) 1987-08-20
SE8202172L (en) 1982-10-07
MY8600571A (en) 1986-12-31
ES8308698A1 (en) 1983-10-01
AU8233482A (en) 1982-10-14
GB2098865B (en) 1985-12-18
DK155882A (en) 1982-12-10
IL65424A0 (en) 1982-07-30
NZ200232A (en) 1985-08-16
DE3212053A1 (en) 1982-10-21
GB2148711B (en) 1985-12-18
GB2148711A (en) 1985-06-05

Similar Documents

Publication Publication Date Title
FI821123L (en) LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT
FI823561A0 (en) PHARMACEUTICAL PRODUCTS FOR END-USE AND PHARMACEUTICAL PRODUCTS
FI822191L (en) PHARMACEUTICAL BLANDING
DK126383D0 (en) TABLET DISPENSER
DK152274C (en) tablet dispenser
DK198582A (en) FORMED CEMENTIC PRODUCTS
DK237884D0 (en) PHARMACEUTICAL PREPARATION
PT73686A (en) PHARMACEUTICAL FORMULATION
DK345682A (en) PHARMACEUTICAL EXPIENSES
IT8248677A0 (en) PHARMACEUTICAL FORMULATIONS
FI850455L (en) PHARMACEUTICAL PRODUCT.
FI862590A0 (en) PHARMACEUTICAL PRODUCT.
DE3279806D1 (en) CORPUSCULES CONTAINING MEDICAMENTS
DK208784D0 (en) PHARMACEUTICAL PRODUCT
FI813412L (en) 3-AMINOPROPOXIPHENYL DERIVATIVES DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
FI810934L (en) PHARMACEUTICAL PRODUCT
FI901938A0 (en) SILVERSULFADIAZINE INNEHAOLLANDE PHARMACEUTICAL PRODUCT FOER LOCAL EXTERNT BRUK.
FI831687L (en) PHARMACEUTICAL BLANDNINGAR VILKA INNEHAOLLER FLERE AKTIVA BESTAONDSDELAR
FI803846L (en) PHARMACEUTICAL PRODUCT
ES529819A0 (en) MEDICINAL PRODUCT CONTAINING MUZOLIMINA
FI822980L (en) FURANOKROMONDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
FI830399A0 (en) MJOELDRYGE ALKALOIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
NL193821B (en) Pharmaceutical preparation.
BE890817A (en) PSCHYCOTROPIC DRUGS
FI813953L (en) BIS-HYDROXIBENZYLDERIVAT DERAS FRAMSTAELLNINGSFOERFARANDEN OCHDESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG